← Back to Search

iPREPARED for Delirium (iPREPARED Trial)

N/A
Waitlist Available
Led By Heidi Lindroth, PhD, RN
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up number approached for study that were eligible and number consented into study over 2-year study.
Awards & highlights

iPREPARED Trial Summary

This trial is testing if iPREPARED can help reduce delirium in patients during their hospital stay.

iPREPARED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~number approached for study that were eligible and number consented into study over 2-year study.
This trial's timeline: 3 weeks for screening, Varies for treatment, and number approached for study that were eligible and number consented into study over 2-year study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Delirium incidence
Feasibility of study recruitment to intervention study
Usability and acceptability of digital technology
Secondary outcome measures
30-day readmission rates
Acute Stress associated with the hospitalization
Biomarkers
+6 more

iPREPARED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IPREPARED Hospital Recovery ClubExperimental Treatment1 Intervention
Participants and their recovery partners (informal caregivers) will use the iPREPARED mobile health technology. They will watch a short video to prepare them for their hospital stay and asked to use the provided resources and tools to maintain their brain health during their hospital stay.
Group II: Standard Hospital Care GroupActive Control1 Intervention
Participants will receive standard protocolized care procedures.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,766,953 Total Patients Enrolled
4 Trials studying Delirium
662 Patients Enrolled for Delirium
Heidi Lindroth, PhD, RNPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What overarching goals are researchers attempting to achieve through this trial?

"This two-year trial will evaluate the number of patients that were eligible and consented into the study as well how usable digital technology is. Secondary assessments include 30-day readmission rates, discharge disposition (e.g. home or rehabilitation facility), and delirium severity using Delirium Rating Scale - R-98 twice daily on hospital days 1-4 and at discharge time."

Answered by AI

Is it still possible to register for this experimental program?

"Affirmative. Records from clinicaltrials.gov reveal that this medical experiment, which first appeared on December 16th 2021, is still actively searching for test participants. A total of 120 people are needed to be enrolled at a single location."

Answered by AI

What is the total enrollment capacity of this research endeavor?

"Affirmative. Clinicaltrials.gov's data suggests that this clinical trial is currently searching for subjects, having been published on December 16th 2021 and lastly revised December 21st 2021. It calls for 120 participants from one site in total."

Answered by AI
~24 spots leftby Dec 2024